NEWS RELEASE, 15 FEBRUARY 2024
Antofagasta 2023 full Year Results
PRESENTATION AND Conference call Details
Antofagasta plc (the Company) will release its results for the full year ended 31 December 2023 on Tuesday 20 February 2024.
Announcement and presentation slides
The 2023 Full Year Results announcement and presentation slides will be available on the Company's website www.antofagasta.co.uk from 7:00 am (UK time) on 20 February 2024. A transcript of the presentation will be made available on the Company's website following the call.
Presentation and Q&A
On behalf of the Company, we invite you to participate in a hybrid meeting hosted by Iván Arriagada - Chief Executive Officer, Mauricio Ortiz - Chief Financial Officer, and René Aguilar - Vice President of Corporate Affairs and Sustainability, which will be open to all investors.
Date 20 February 2024
Time 9:00 am (UK time)
Venue Church House Westminster, Dean's Yard, London SW1P 3NZ
Online link Please join the conference online here.
Meeting ID 9629 349 0666
Passcode 112180
For those investors who are not able to join the conference either in-person or online, you can join by telephone using the dial-in details here. You will be able to hear the presentation, the Q&A, and ask questions.
Video and telephone participants will have to register before they can participate in the call, therefore please aim to leave enough time to do this before the call begins.
|
Investors - London |
|
Media - London | |
| Rosario Orchard | Carole Cable | ||
| Robert Simmons | Telephone | +44 20 7404 5959 | |
| Telephone | +44 20 7808 0988 | | |
|
|
|
|
|
|
|
| Media - Santiago | |
| | | Pablo Orozco | |
| | | Carolina Pica | |
| | | Telephone | +56 2 2798 7000 |
Register on our website to receive our email alerts at the following address: https://www.antofagasta.co.uk/investors/news/email-alerts/
| |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
